Hurley Capital’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$251 Hold
29
– – ﹤0.01% 624
2026
Q2
$363 Hold
29
– – ﹤0.01% 627
2026
Q1
$432 Hold
29
– – ﹤0.01% 622
2025
Q4
$725 Buy
+29
New +$516 ﹤0.01% 533

Other funds holding OLMA

Hurley Capital's OLMA Position: Q3 2026 in Review

Hurley Capital held its Olema Oncology (OLMA) position steady in Q3 2026 at 29 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #624.

Hurley Capital first reported a position in OLMA in Q4 2025 and has held it in 4 quarters since. The position peaked at $725 in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Hurley Capital held 29 shares of Olema Oncology worth $251 as of Q3 2026.
  • Hurley Capital left its Olema Oncology share count unchanged in Q3 2026.
  • Olema Oncology made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #624 holding.
  • Hurley Capital first reported a position in Olema Oncology in Q4 2025 and has held it in 4 quarters since.
  • Hurley Capital's Olema Oncology position peaked at $725 in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.